RBDCOV

RBDCOV, a clinical trial towards a COVID-19 vaccine for children, adolescents and immunocompromised people using a recombinant protein... RBDCOV aims to generate robust data to demonstrate the safety and immunogenicity* of this vaccine given as a booster* vaccination to induce a higher and more durable immune response*, for potential new variants... RBDCOV aims to test the efficacy, tolerability, and safety of the HIPRA vaccine for COVID-19. HIPRA's vaccine is an adjuvanted recombinant protein vaccine, based on a receptor binding domain (RBD) fusion heterodimer against SARS-CoV-2.